Mizuho initiated coverage on CASI Pharmaceuticals with a new price target
$CASI
Biotechnology: Pharmaceutical Preparations
Health Care
Mizuho initiated coverage of CASI Pharmaceuticals with a rating of Buy and set a new price target of $3.80
Save time and jump to the most important pieces.